"Shifa International Hospital is a 550 bed quaternary care hospital in Islamabad offering comprehensive diagnostic facilities, outpatient clinics and inpatient services in 35+ medical & surgical specialties. With Our USA and E.U. trained & qualified Physicians and Surgeons, Shifa aims to provide the highest quality medical care to all patients with care & compassion in an environment conducive to the practice of good medicine."

During the past decade, Shifa International Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shifa International Hospital" #1 sponsor was "Population Health Research Institute" with 2 trials, followed by "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials sponsored, "CanSino Biologics Inc." with 1 trials sponsored, "Jerry Zimmerman" with 1 trials sponsored and "Livzon Pharmaceutical Group Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shifa International Hospital" #1 collaborator was "Hamilton Health Sciences Corporation" with 3 trials as a collaborator, "Beijing Institute of Biotechnology" with 1 trials as a collaborator, "Canadian Critical Care Trials Group" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Children's Hospital of Eastern Ontario" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Shifa International Hospital" are "Atrial Fibrillation" (2 trials), "Acute Respiratory Failure" (1 trials), "Atrial Flutter" (1 trials), "COVID-19" (1 trials) and "COVID-19 Pandemic" (1 trials). Many other conditions were trialed in "Shifa International Hospital" in a lesser frequency.

Most popular intervention types in "Shifa International Hospital" are "Drug" (3 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Accelerated medical clearance and surgery" (1 trials), "Active release technique alongwith conventional treatment" (1 trials), "Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)" (1 trials) and "Colchicine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shifa International Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Shifa International Hospital". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Shifa International Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shifa International Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Shifa International Hospital has several departments that took part in Clinical trials: "Shifa International Hospital; Department of Oncology" - 2 trials